1. Signaling Pathways
  2. Anti-infection
  3. HSV
  4. HSV Inhibitors

HSV Inhibitors

HSV-1

HSV-2

HSV

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

HSV Inhibitors
Product Name HSV-1 HSV-2 HSV Purity
2-Deoxy-D-glucose
HSV-1
    99.93%
Brefeldin A
HSV-1
    99.82%
Cytarabine
HSV-1
    99.98%
Dynasore
HSV-1
HSV-2
  99.85%
Imiquimod
HSV-1
    99.96%
Ivermectin
HSV-1
    98.01%
Salubrinal
HSV-1
    99.69%
Ganciclovir
HSV-1
HSV-2
  99.77%
Acyclovir
HSV-1, IC50: 0.85 μM
HSV-2, IC50: 0.86 μM
  99.34%
Imiquimod hydrochloride
HSV-1
    99.77%
Floxuridine    
HSV
99.95%
Ginsenoside Rb1
HSV-1
    98.75%
Digitoxin
HSV-1
    99.36%
Xanthohumol
HSV-1
HSV-2
  99.47%
Trifluridine
HSV-1
HSV-2
  99.98%
Surfactin
HSV-1
HSV-2
  98.96%
Theaflavin 3,3'-digallate    
HSV
99.73%
Levamisole hydrochloride
HSV-1
    99.87%
Ganciclovir sodium
HSV-1
HSV-2
  99.79%
Oxytetracycline
HSV-1
    99.05%
Surfen dihydrochloride
HSV-1
    ≥99.0%
Pritelivir
HSV-1, IC50: 0.02 μM
HSV-2, IC50: 0.02 μM
  99.03%
FSL-1 TFA  
HSV-2
  99.76%
Adenosine 5'-monophosphate monohydrate
HSV-1
HSV-2
  99.07%
Betulonic acid
HSV-1
    98.06%
Penciclovir
HSV-1, EC50: 0.5 μg/mL
HSV-2, EC50: 0.8 μg/mL
  99.90%
Vidarabine
HSV-1, IC50: 9.3 μg/mL
HSV-2, IC50: 11.3 μg/mL
  99.35%
Oxyresveratrol
HSV-1
HSV-2
  99.73%
Valacyclovir hydrochloride
HSV-1, IC50: 2.9 μg/mL
    99.85%
LDC4297
HSV-1, EC50: 0.02 μM
HSV-2, EC50: 0.27 μM
  98.25%
Octyl gallate
HSV-1
    98.01%
Amenamevir
HSV-1, IC50: 7.7-20 ng/mL
HSV-2, IC50: 15-58 ng/mL
  99.89%
BIO-acetoxime
HSV-1
    ≥98.0%
Oxytetracycline hydrochloride
HSV-1
    98.73%
Pinostrobin
HSV-1
    99.98%
Soyasaponin II
HSV-1, IC50: 54 μM
    99.81%
FIT-039
HSV-1, IC50: 0.69 μM
    99.56%
Brassicasterol
HSV-1, IC50: 1.2 μM
    98.71%
SIBA
HSV-1
    99.66%
Isoborneol
HSV-1
    ≥98.0%
Imiquimod maleate
HSV-1
    99.25%
Manzamine A hydrochloride
HSV-1
    99.66%
Histone H4 (2-21)
HSV-1
    98.17%
Docusate Sodium
HSV-1
HSV-2
  ≥98.0%
LDC4297 hydrochloride
166v VP22-GFP, EC50: 0.02 μM
01-6332, EC50: 0.27 μM
  98.25%
Isoxanthohumol
HSV-1
HSV-2
  99.90%
Tromantadine hydrochloride
HSV-1
HSV-2
  ≥98.0%
AT-533
HSV-1
    98.86%
Soyasapogenol C
HSV-1
    ≥99.0%
Fiacitabine
HSV-1
HSV-2
  98.83%
Pritelivir mesylate hydrate
HSV-1, IC50: 0.02 μM
HSV-2, IC50: 0.02 μM
  99.51%
Pritelivir mesylate
HSV-1, IC50: 0.02 μM
HSV-2, IC50: 0.02 μM
  99.51%
5-Nitrobarbituric acid
HSV-1, IC50: 1.7 μM
    99.91%
B220
HSV-1
HSV-2
  ≥99.0%
Tromantadine
HSV-1
HSV-2
  ≥99.0%
Valacyclovir
HSV-1, IC50: 2.9 μg/mL
   
Acyclovir sodium
HSV-1, IC50: 0.85 μM
HSV-2, IC50: 0.86 μM
 
Penciclovir sodium
HSV-1, EC50: 0.5 μg/mL
HSV-2, EC50: 0.8 μg/mL
 
Ganciclovir hydrate
HSV-1
HSV-2
 
Oxytetracycline calcium
HSV-1
   
Leachianone G
HSV-1, IC50: 1.6 μg/mL
   
Perillic acid
HSV-1
   
Ganoderone A    
HSV, IC50: 0.3 μg/mL
Kushenol K  
HSV-2, EC50: 147 μM
 
Ginsenoside Rb1 (Standard)
HSV-1
   
Peniterphenyl A
HSV-1
   
Manzamine A
HSV-1
   
HSV-1/HSV-2-IN-2
HSV-1, EC50: 6.8 μM
HSV-2, EC50: 8.9 μM
 
Yatein
HSV-1
    99.76%
Stearyl gallate
HSV-1
   
HSV-1-IN-1
HSV-1, IC50: 0.5 nM
HSV-2, IC50: 16 nM
 
HSV-1/HSV-2-IN-1
HSV-1
HSV-2
 
Oxytetracycline dihydrate
HSV-1
   
SCH-43478  
HSV-2, IC50: 1.8 μg/mL
 
BRL44385
HSV-1
HSV-2